No MSH6 germline mutations in breast cancer families with colorectal and/or endometrial cancer

Background: The genetic background in breast cancer families with colorectal and/or endometrial cancer is mostly unknown. The functional connection between MSH6 and the known breast cancer predisposition gene product BRCA1 suggests that the MSH6 gene may also play a role in breast cancer predisposition. Methods: We analysed 38 breast cancer families with colorectal and/or endometrial cancer for germline mutations in MSH6. Results: No disease associated mutations were detected among the breast cancer families. However, mutation analysis revealed a Glu995STOP mutation in an atypical HNPCC family. The same mutation was found in a patient with both breast and colorectal carcinoma in our previous study, and haplotype analysis confirmed a common ancestral origin. The Glu995STOP mutation was further examined in an extensive series of 245 colorectal and 142 breast carcinoma patients with a family history of breast, colorectal, and/or endometrial carcinoma, and in 268 healthy population controls, but none was found to carry the mutation. Conclusions: Our results suggest that MSH6 may not be the underlying gene in breast cancer families with a history of colorectal and/or endometrial cancer. The Glu995STOP founder mutation is not a familial breast cancer predisposition allele and makes only a limited contribution to colorectal cancer burden in Finland.

[1]  K. McKenzie,et al.  Frequent p53 gene mutations and novel alleles in familial breast cancer. , 1994, Cancer research.

[2]  H. Schackert,et al.  Involvement of hMSH6 in the development of hereditary and sporadic colorectal cancer revealed by immunostaining is based on germline mutations, but rarely on somatic inactivation , 2002, International journal of cancer.

[3]  L. Lipton,et al.  Contribution of the CHEK2 1100delC variant to risk of multiple colorectal adenoma and carcinoma. , 2003, Cancer letters.

[4]  S. Goodman,et al.  Very high risk of cancer in familial Peutz-Jeghers syndrome. , 2000, Gastroenterology.

[5]  J. Boyd,et al.  Male breast cancer in the hereditary nonpolyposis colorectal cancer syndrome , 2004, Breast Cancer Research and Treatment.

[6]  L. Aaltonen,et al.  CHEK2 1100delC and colorectal cancer , 2003, Journal of medical genetics.

[7]  H. Nevanlinna,et al.  A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families , 2001, British Journal of Cancer.

[8]  Y. Muto,et al.  Analyses of microsatellite instability and the transforming growth factor‐β receptor type II gene mutation in sporadic breast cancer and their correlation with clinicopathological features , 2004, Breast Cancer Research and Treatment.

[9]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[10]  Y. Yuasa.  [Hereditary nonpolyposis colorectal cancer]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.

[11]  P. Møller,et al.  Familial endometrial cancer in female carriers of MSH6 germline mutations , 1999, Nature Genetics.

[12]  Wei Yang,et al.  Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA , 2000, Nature.

[13]  K. Kinzler,et al.  Molecular cloning of the N-terminus of GTBP. , 1996, Genomics.

[14]  H. Olsson.  Cancer risks in BRCA2 mutation carriers. , 1999, Journal of the National Cancer Institute.

[15]  Akihiro Matsumoto,et al.  Hepatocellular carcinoma: recent trends in Japan. , 2004, Gastroenterology.

[16]  R. Houlston,et al.  Risk of cancer death in first‐degree relatives of patients with hereditary non‐polyposis cancer syndrome (Lynch type II): A study of 130 kindreds in the United Kingdom , 1990, The British journal of surgery.

[17]  C. Sutter,et al.  Eight novel MSH6 germline mutations in patients with familial and nonfamilial colorectal cancer selected by loss of protein expression in tumor tissue , 2004, Human mutation.

[18]  J. Russo,et al.  Mutations in mismatch repair genes are involved in the neoplastic transformation of human breast epithelial cells. , 2003, International journal of oncology.

[19]  W. Foulkes,et al.  MSI‐low, a real phenomenon which varies in frequency among cancer types , 2003, The Journal of pathology.

[20]  P. Møller,et al.  Prediction of a mismatch repair gene defect by microsatellite instability and immunohistochemical analysis in endometrial tumours from HNPCC patients , 2000, The Journal of pathology.

[21]  J. Tytell,et al.  Germ-line msh6 mutations in colorectal cancer families. , 1999, Cancer research.

[22]  J. Jiricny,et al.  GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. , 1995, Science.

[23]  L. Aaltonen,et al.  Population-based molecular detection of hereditary nonpolyposis colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  H. Hollema,et al.  Molecular and clinical characteristics of MSH6 variants: an analysis of 25 index carriers of a germline variant. , 2002, American journal of human genetics.

[25]  L. Aaltonen,et al.  Cancer risk in mutation carriers of DNA‐mismatch‐repair genes , 1999, International journal of cancer.

[26]  K Holli,et al.  Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.

[27]  B. Ponder,et al.  A low proportion of BRCA2 mutations in Finnish breast cancer families. , 1997, American journal of human genetics.

[28]  H. Hollema,et al.  Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. , 1999, American journal of human genetics.

[29]  L. Lipton,et al.  Apparent Mendelian inheritance of breast and colorectal cancer: chance, genetic heterogeneity or a new gene? , 2004, Familial Cancer.

[30]  L. Aaltonen,et al.  p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. , 2001, Cancer research.

[31]  The Polish Breast Cancer Consortium.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002 .

[32]  Nazneen Rahman,et al.  Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.

[33]  Y. Yuasa,et al.  Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. , 1997, Cancer research.

[34]  J. Rüschoff,et al.  Sequence analysis of the mismatch repair gene hMSH6 in the germline of patients with familial and sporadic colorectal cancer , 2000, International journal of cancer.

[35]  M. Koike,et al.  Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer , 1997, Nature Genetics.

[36]  R. Scott,et al.  Hereditary nonpolyposis colorectal cancer in 95 families: differences and similarities between mutation-positive and mutation-negative kindreds. , 2001, American journal of human genetics.

[37]  O. Kallioniemi,et al.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. , 2002, American journal of human genetics.

[38]  H. Grönberg,et al.  MSH6 and MSH3 are rarely involved in genetic predisposition to nonpolypotic colon cancer. , 2001, Cancer research.

[39]  J. Klijn,et al.  The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. , 2003, American journal of human genetics.

[40]  B. Rosen,et al.  Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. , 2001, American journal of human genetics.

[41]  P. Modrich,et al.  Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. , 1995, Science.

[42]  J. Mecklin,et al.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) , 1991, Diseases of the colon and rectum.

[43]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[44]  J. Knezetic,et al.  Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members. , 1999, Cancer genetics and cytogenetics.

[45]  S. Sukumar,et al.  Frequent p 53 Gene Mutations and Novel Alleles in Familial Breast Cancer ' , 2006 .

[46]  P. Pérez-Segura,et al.  Low frequency of microsatellite instability in sporadic breast cancer. , 2000, International journal of oncology.

[47]  J. Boyd,et al.  Molecular genetic evidence of the occurrence of breast cancer as an integral tumor in patients with the hereditary nonpolyposis colorectal carcinoma syndrome , 1996, Cancer.

[48]  A. Zwinderman,et al.  Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree , 2001, Journal of medical genetics.

[49]  O. Kallioniemi,et al.  Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. , 1997, Human molecular genetics.

[50]  J. Jiricny,et al.  hMutSβ, a heterodimer of hMSH2 and hMSH3, binds to insertion/deletion loops in DNA , 1996, Current Biology.

[51]  S. Elledge,et al.  BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. , 2000, Genes & development.

[52]  G. Marsischky,et al.  hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[53]  H. Iwata,et al.  Microsatellite instability in sporadic human breast cancers , 1996, International journal of cancer.

[54]  Douglas F Easton,et al.  Cancer Incidence in BRCA1 mutation carriers. , 2002, Journal of the National Cancer Institute.

[55]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[56]  T. Sellers,et al.  Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history , 1993, Genetic epidemiology.

[57]  H. Morreau,et al.  Is breast cancer part of the tumor spectrum of hereditary nonpolyposis colorectal cancer? , 2001, American journal of human genetics.

[58]  L. Aaltonen,et al.  Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. , 1998, The New England journal of medicine.

[59]  P. Møller,et al.  Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. , 2004, Gastroenterology.